Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).

By A. Grothey, M. Sugrue, D. Purdie, W. Dong, D. Sargent, E. Hedrick, M. Kozloff. Journal of Clinical Oncology, 2008

673 citations recorded by the source corpus.

Subfields: Oncology

View Paper: https://www.semanticscholar.org/paper/a6642dda4023588a6b4dfec83c030f7dfe195420

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. N. Vasudev
2. Andrew R Reynolds
3. Rakesh K. Jain

Citations in the corpus

• Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions (2014, background): “greater benefit in terms of overall survival [91].”